Interview With CEO Dr. Parmjot Bains About The Bioimpedance Spectroscopy Technology Leader
In this interview with Pulse 2.0, CEO and Managing Director Dr. Parmjot Bains shares how our SOZO® platform is reshaping care for breast cancer survivors through early lymphedema detection.
×